Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q86UV6
UPID:
TRI74_HUMAN
Alternative names:
Tripartite motif-containing protein 50C
Alternative UPACC:
Q86UV6; B7WP46
Background:
The Tripartite motif-containing protein 74, also known as Tripartite motif-containing protein 50C, is a protein of interest in the field of molecular biology. Its unique structure, characterized by the presence of a tripartite motif, suggests a specialized function within cellular processes.
Therapeutic significance:
Understanding the role of Tripartite motif-containing protein 74 could open doors to potential therapeutic strategies. Its unique molecular characteristics make it a promising target for drug discovery, aiming to modulate its function for therapeutic benefits.